Apixaban in Patients With Left Ventricular Thrombus
Status:
Completed
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
Open label randomized controlled clinical trial to evaluate the efficacy and safety of
apixaban versus warfarin in treating left ventricular thrombus in patients with acute or
recent myocardial infarction (MI).